Crinetics Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Crinetics Pharmaceuticals, Inc. (CRNX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of -0.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-02-26
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was -0.90%.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2024 was -0.84%.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2023 was -0.08%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|
| 2025-12-31 | -0.90% 10-K · filed 2026-02-26 |
| 2024-12-31 | -0.84% 10-K · filed 2026-02-26 |
| 2023-12-31 | -0.08% 10-K · filed 2026-02-26 |